NATIONAL PRESTO INDUSTRIES INC

NPK
About the company

National Presto Industries, Inc. provides houseware and small appliance, defense, and safety products in North America.

Country: United StatesPrice: $139.11Market Cap: $992.7M

Investment snapshot

12%positive consensus
Scored 1d ago

Positive

2

BUY / PASS

Neutral / negative

3 / 11

NEUTRAL / FAIL

Median fair value

$89.95

-35.3% vs price

Models with upside

0 / 17

Positive margin of safety

Strongest signal

9 of 12 pass — Graham, Lynch and Marks object

Key risk

No clean pass — all 13 investors flag at least one valuation criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #1504 (Top 48.6%)FAILFAILPASSFAILFAILFAILFAILFAILNEUTRALBUYFAILNEUTRALNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/A-212.3%N/AN/AN/AN/A-13.6%-54.7%N/AN/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-07-05 · Balance sheet at 2026-07-05 · Annual history · FY 2025

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-13

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-07-05 · TTM ended 2026-07-05

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-13

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-13

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-07-05 · Balance sheet at 2026-07-05 · Market data at 2026-11-01

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-07-05 · Balance sheet at 2026-07-05

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-13

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-07-05 · Balance sheet at 2026-07-05

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-13

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-07-05 · Balance sheet at 2026-07-05 · Market data at 2026-11-01

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-07-05

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-13

Score computed: 2026-11-14

TTM ended 2026-07-05 · Balance sheet at 2026-07-05 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-07-05

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-07-05

Latest source filing: 2026-08-14

Score computed: 2026-11-14

TTM ended 2026-07-05 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-08-14

Score computed: 2026-11-14

Where It Passes

  • Debt & Leverage75% pass✓ 12✗ 3▾

    9 of 12 pass — Graham, Lynch and Marks object

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.06, IC: 48.4x
    ✓BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0
    ✓Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities5.22
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=48.4x, D/EBITDA=N/A (D&A unavailable)
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.0000; #1/4210 (top 0.0%)
    ✓AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Valuation0% pass✓ 2✗ 26▾

    No clean pass — all 13 investors flag at least one valuation criterion

    Net income / market capitalization+4.31%; #1900/6340 (top 30.0%)
    ✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio2.5x
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value4.0%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=4.0%, ROC=10.9%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    Price / Book Value per Share2.5x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation Reasonableness
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=-3.6%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=2.5x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value
    ✗Marks>= 20% below intrinsic value
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Price vs. Trailing Low165% of trailing low ($84.35)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Positive book equity / market capitalization+0.4143; #3209/6449 (top 49.8%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share2.65x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change+4.1%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.5487; #2505/5247 (top 47.7%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+2.66%; #2115/4519 (top 46.8%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-1.23%; #2875/6202 (top 46.4%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Valuation models0% pass✗ 3▾

    NPK overvalued: all 3 models price fair value below $139.11 (median $89.95)

    Greenblatt fair value$44.54
    ✗Greenblatt-212.3% margin vs $139.11
    Akre fair value$122.48
    ✗Akre-13.6% margin vs $139.11
    Marks fair value$89.95
    ✗Marks-54.7% margin vs $139.11
  • Profitability6% pass✓ 7✗ 28▾

    15 of 16 flag NPK's profitability — Graham, Buffett, Lynch +12 more

    Net income / market capitalization+4.31%; #1900/6340 (top 30.0%)
    ✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive EPS (10 years)22/26 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)26/26 years positive
    ✓BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)8.5%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)8.0% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$38.7M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR-10.7%
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE10.4%
    ✗Lynch> 15%
    EBIT / Enterprise Value4.0%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=4.0%, ROC=10.9%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets6.61%
    ✓PiotroskiROA > 0
    ROA Change YoY9.14% -> 6.61% (delta: -2.54%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=-1.82%, ROA=6.61%
    ✗PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY20.2% -> 16.0%
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue10.0%
    ✓Dreman>= 8%
    Net Income / Shareholders' Equity10.4%
    ✗Dreman> 12%
    Margin of SafetyP/B=2.5x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity9.8% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency26/26 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue9.6%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity10.4%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend10.3% (2023) -> 8.0% (2025)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 19.8% -> 16.0%, operating margin 10.3% -> 8.0%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Gross profit / total assets+17.99%; #2195/3702 (top 59.3%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+10.41%; #1753/5226 (top 33.5%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0143; #1097/5884 (top 18.6%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR-10.7% over 5 years
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years6/6 years positive
    ✓Schloss>= 70% positive over 5-10 observed years (app rule)
  • Growth13% pass✓ 4✗ 9▾

    7 of 8 flag NPK's growth — Graham, Lynch, Dreman +4 more

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR-10.7%
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: 10.4% vs Rev: 29.7%
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency26/26 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth13.9%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency0/1 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 19.8% -> 16.0%, operating margin 10.3% -> 8.0%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR7.4%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR-10.7% over 5 years
    ✗Neff7%-20% annualized
  • Verdicts14% pass✓ 2✗ 12▾

    Split decision: 11 FAIL · 3 NEUTRAL · 1 PASS · 1 BUY

    Overall verdict
    ✗GrahamFAIL (2/9)✗BuffettFAIL (2/9)✗LynchFAIL (2/7)✗GreenblattRank #1504✗PiotroskiFAIL (F-Score 3)✗DremanFAIL (3/11)✓MungerPASS (2/4)✗PabraiFAIL (0/3)✗AkreFAIL (2/6)✗MarksFAIL (2/5)✗AckmanFAIL (3/9)✗TempletonFAIL (3/8)•SleepNEUTRAL (4/6)✓AsnessBUY (Rank #52/2370 (Top 2.2%))✗NeffFAIL (3/6)•SchlossNEUTRAL (5/7)•OshaughnessyNEUTRAL (Not ranked)
  • Efficiency25% pass✓ 3✗ 8▾

    6 of 8 flag NPK's efficiency — Buffett, Greenblatt, Piotroski +3 more

    Current Ratio5.22
    ✓Graham>= 2.0
    ROIC (3-5 yr avg)8.9%
    ✗Buffett> 10%
    ROIC - WACC-1.1%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)10.9%
    ✗Greenblatt> 25%
    Current Ratio Change YoY4.93 -> 4.24
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.86x -> 1.01x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities5.22
    ✓Dreman> 1.5
    Return on Invested Capital10.1%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=9.7%; FY2025: ROIC=7.6%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC8.4% (RR=83% x ROIC=10.1%)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/2 years above 12% (latest 7.6%)
    ✗SleepROIC > 12% in a majority of years
  • Cash Flow30% pass✓ 3✗ 9▾

    7 of 10 flag NPK's cash flow — Buffett, Lynch, Piotroski +4 more

    Free Cash Flow Proxy$38.7M
    ✗BuffettPositive and growing
    FCF Positive and Growing$-36.2M
    ✗LynchPositive and growing
    Operating Cash Flow$-9.1M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=-1.82%, ROA=6.61%
    ✗PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    P/E or FCF YieldFCF Yield=-3.6%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive14/17 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap2.7%
    ✗Ackman>= 4%
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency22/24 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$26.4M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+2.66%; #2115/4519 (top 46.8%)
    ✗OshaughnessyTop 10% of eligible cross-section

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Defense
SIC Sector: Fabricated Metals
Size: Small Cap($992.7M)
Revenue: $503.5M+29.7% YoY
Net Income: $33.1M-20.2% YoY

Financial Snapshot

Operating Margin8.0%
Return on Equity8.4%
Debt / Equity0.06
Current Ratio4.24
Shares Retired−0.2% / −0.5% 2y

Shareholder Return

Fiscal 2025

Issued 0.2% of shares last year, 0.5% issued over two.

Buybacks
—
Dividends
$7.1M

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-10-04

2025-09-29 – 2026-10-04

Sources · derived quarter values

Derived from cumulative filings: operating income, ebit, pre tax income, operating cash flow, capex, dividends paid.

Q3 FY 2026

2026-07-06 – 2026-10-04

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, dividends paid.

Q2 FY 2026

2026-04-06 – 2026-07-05

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, dividends paid.

Q1 FY 2026

2026-01-01 – 2026-04-05

Sources
FY 2025
Sources
  • 10-K · 2026-03-13
FY 2024
Sources
  • 10-K · 2025-03-14
FY 2023
Sources
  • 10-K · 2024-03-15
FY 2022
Sources
  • 10-K · 2023-03-13
FY 2021
Sources
  • 10-K · 2022-03-11
Market Cap$992.7Mcurrent------$900.9Mest.$671.5Mest.$520.0Mest.$475.1Mest.$481.2Mest.
Revenue$573.5M$144.3M↑25%$146.6M↑22%$118.6M↑14%$503.5M↑30%$388.2M↑14%$340.9M↑6%$321.6M↓10%$355.8M
Operating Income$70.8M$24.7M↑286%$19.4M↑218%$8.0M↓11%$40.2M↓11%$45.2M↑29%$35.0M↑58%$22.1M↓26%$30.0M
Net Income$57.5M$20.0M↑276%$15.9M↑208%$6.6M↓13%$33.1M↓20%$41.5M↑20%$34.6M↑67%$20.7M↓19%$25.7M
EPS (Diluted)----------------$3.63
Gross Margin18.7%23.4%↑69%19.5%↑26%14.7%↓16%16.0%↓21%20.2%↑2%19.8%↑15%17.1%↓5%18.1%
Operating Margin12.4%17.1%↑209%13.2%↑162%6.8%↓23%8.0%↓31%11.6%↑13%10.3%↑49%6.9%↓18%8.4%
ROE13.3%———8.4%↓26%11.3%↑16%9.7%↑63%5.9%↓17%7.2%
Total Debt$0$0↓100%$0↓100%--$23.6M$0------
Shareholders' Equity$431.7M$431.7M↑14%$411.3M↑10%$395.2M↑7%$395.1M↑7%$367.6M↑3%$356.3M↑2%$348.1M↓3%$357.6M
Current Ratio4.764.76↑35%5.22↑24%—4.24↓14%4.93↓1%5.00↓18%6.09↓7%6.55
Debt / Equity0.000.00↓100%0.00↓100%—0.060.00———
Operating Cash Flow$60.7M$2.7M↑111%$12.8M$31.3M↑152%-$9.1M↑83%-$53.4M↓218%$45.4M↑418%$8.8M↓75%$34.7M
Free Cash Flow$46.7M-$4.5M↑82%$9.3M$29.4M↑379%-$36.2M↑41%-$61.0M↓240%$43.5M↑463%$7.7M↓76%$31.8M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Defense

NPK vs Peers — Financial Grading

Revenue$503.5MMedian
Net Income$33.1MTop 25%
ROE8.4%Top 25%
D/E0.06Median
Op. Margin8.0%Top 25%
Curr. Ratio4.24Top 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
LOCKHEED MARTIN CORPLMT$137.7B$596.04$75.0B$5.0B74.6%3.2310.3%1.092/95/93/71/3F-Score 63/11
Rocket Lab CorpRKLB$41.4B$61.53$601.8M$198.2M-11.5%0.00-38.0%4.083/91/92/70/3F-Score 53/11
AXON ENTERPRISE, INC.AXON$25.7B$315.43$2.8B$124.7M3.8%0.56-2.2%2.532/91/90/70/3F-Score 53/11
KRATOS DEFENSE & SECURITY SOLUTIONS, INC.KTOS$6.4B$33.91$1.3B$22.0M1.1%0.001.9%4.063/91/93/70/3F-Score 43/11
Firefly Aerospace Inc.FLY$4.3B$25.21$159.9M$298.3M-25.1%0.24-163.1%4.514/90/93/70/3F-Score 53/11
Redwire CorpRDW$1.9B$7.73$335.4M$226.6M-21.4%0.08-68.5%1.624/91/92/70/3F-Score 43/11
Voyager Technologies, Inc./TXVOYG$1.7B$27.04$166.4M$104.8M-27.3%1.17-65.2%4.372/90/90/70/3F-Score 42/11
STURM RUGER & CO INCRGR$806.1M$50.45$546.1M$4.4M-1.5%—-2.3%3.873/92/92/70/3F-Score 51/11